此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Effectiveness of "CARE Coaching Model" as an Effort to Empower Type 2 Diabetes Mellitus Patients

2022年11月1日 更新者:Prof. Dr. dr. Pradana Soewondo, SpPD-KEMD、Indonesia University

Efektivitas "CARE Coaching Model" Sebagai Upaya Pemberdayaan Pasien Diabetes Untuk Meningkatkan Status Kesehatan Dan Perilaku Pengendalian Diabetes

In Indonesia and others countries, only 30.8% patients with type 2 diabetes mellitus (T2DM) achieved glycemic control with HbA1c <7%. Optimal pharmacological treatment alone does not guarantee an optimal outcome, therefore it should be combined with lifestyle management. Health coaching helps T2DM patients increase self awareness to improve and maintain behavior which play a role in self-management. This study aims to evaluate the impact of health coaching on glycemic control on T2DM patients.

研究概览

地位

完全的

条件

详细说明

Subjects randomized into 2 groups: control and intervention group. All subject received education class in top of standard treatment. Intervention group received additional personal health coaching.

Education and health coaching was given for 12 sessions every 2 weeks with 12 different themes for each session. Health coaching were given by International certified health coach.

Laboratory examination and questionnaire collected at baseline, 3 and 6 months after intervention.

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • DKI Jakarta
      • Jakarta Pusat、DKI Jakarta、印度尼西亚、10430
        • Faculty of Medicine, Universitas Indonesia

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

30年 至 60年 (成人)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • T2DM patients
  • aged 30-60 years old
  • HbA1C > 7.5% within the past 3 months
  • able to write and read.

Exclusion Criteria:

  • Patients with cognitive disease (such as dementia)
  • having hearing problem or sight problem
  • unable to live independently on daily basis
  • having disease that may affect HbA1c result (eg: hemolytic anemia)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Control
Conventional Education Class
实验性的:Coaching
Health Coaching
Health Coaching as face to face with a coach

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change from Baseline HbA1c at 3 months
大体时间:3 month after intervention
Glycemic Control
3 month after intervention
Change from Baseline HbA1c at 6 months
大体时间:6 month after intervention
Glycemic Control
6 month after intervention

次要结果测量

结果测量
措施说明
大体时间
Change from Baseline Fasting Plasma Glucose at 3 months
大体时间:3 month after intervention
Glycemic Control
3 month after intervention
Change from Baseline 2-hours post prandial plasma glucose at 3 months
大体时间:3 months after intervention
Glycemic control
3 months after intervention
Change from HDL-cholesterol at 3 months
大体时间:3 months after intervention
Diabetes mellitus control
3 months after intervention
Change from LDL-cholesterol at 3 months
大体时间:3 months after intervention
Diabetes mellitus control
3 months after intervention
Change from Triglycerides at 3 months
大体时间:3 months after intervention
diabetes mellitus control
3 months after intervention
Change from Total Cholesterol at 3 months
大体时间:3 months after intervention
Diabetes mellitus control
3 months after intervention
Change of Body mass index at 3 months
大体时间:3 month after intervention
Diabetes mellitus control
3 month after intervention
Change calorie intake at 3 months
大体时间:3 month after intervention
life style parameter
3 month after intervention
International Physical Activity Questionnaire (IPAQ) questionnaire
大体时间:baseline, 3 month and 6 months after intervention
consist of several question about activities in the whole week. Scoring divided into 3 categories : low, moderate, high. This questionnaire is to describe activities no to divided whether high score means good or bad
baseline, 3 month and 6 months after intervention
EQ-5D quality of life questionnaire
大体时间:baseline, 3 month and 6 months after intervention
This questionnaire consist of several question with 5 main outcome mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Subjects will answer the question with fully, half or none.
baseline, 3 month and 6 months after intervention
Change from Baseline Fasting Plasma Glucose at 6 months
大体时间:6 month after intervention
Glycemic Control
6 month after intervention
Change from Baseline 2-hours post prandial plasma glucose at 6 months
大体时间:6 months after intervention
Glycemic Control
6 months after intervention
Change from HDL-cholesterol at 6 months
大体时间:6 months after intervention
diabetes mellitus Control
6 months after intervention
Change from LDL-cholesterol at 6 months
大体时间:6 months after intervention
diabetes mellitus Control
6 months after intervention
Change from Triglycerides at 6 months
大体时间:6 months after intervention
diabetes mellitus Control
6 months after intervention
Change from Total Cholesterol at 6 months
大体时间:6 months after intervention
diabetes mellitus Control
6 months after intervention
Change from systolic and diastolic blood pressure at 6 months
大体时间:6 months after intervention
diabetes mellitus Control
6 months after intervention
Change calorie intake at 6 months
大体时间:6 months after intervention
life style parameter
6 months after intervention
Change of Body mass index at 6 months
大体时间:6 months after intervention
diabetes mellitus control
6 months after intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Pradana Soewondo, Prof、Fakultas Kedokteran Universitas Indonesia

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年2月1日

初级完成 (实际的)

2018年8月31日

研究完成 (实际的)

2020年3月31日

研究注册日期

首次提交

2020年2月10日

首先提交符合 QC 标准的

2020年2月27日

首次发布 (实际的)

2020年2月28日

研究记录更新

最后更新发布 (实际的)

2022年11月2日

上次提交的符合 QC 标准的更新

2022年11月1日

最后验证

2022年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • PS002

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅